Intercept to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

Interpept将于2021年2月25日公布2020年第四季度及全年财务业绩

2021-02-11 23:00:12 BioSpace

本文共619个字,阅读需2分钟

NEW YORK, Feb. 11, 2021 -- Intercept Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its fourth quarter and full year 2020 financial results prior to market open on Thursday, February 25, 2021. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results. The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 7565656. Archived webcasts will be available on Intercept’s website for approximately two weeks. About Intercept Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn. CONTACT For more information about Intercept, please contact: Investor inquiries: investors@interceptpharma.com Media inquiries: media@interceptpharma.com Source: Intercept Pharmaceuticals, Inc.
2021年2月11日,纽约--专注于开发和商业化治疗进展性非病毒性肝病的新型疗法的生物制药公司Intercept Pharmaceuticals,Inc.将在2021年2月25日(星期四)开市前公布其第四季度和2020年全年财务业绩。宣布之后,将于美国东部时间上午8:30由Intercept管理层主持召开电话会议和音频网络广播,讨论结果。 电话会议可在我们网站的投资者网页上查阅,网址为http://ir.interceptpharma.com或拨打(855)232-3919(国内免费电话)或(315)625-6894(国际)密码7565656。存档的网播将在Intercept的网站上提供大约两周的时间。 关于截取 Intercept是一家生物制药公司,专注于新型治疗药物的开发和商业化,用于治疗进展性非病毒性肝病,包括原发性胆道胆管炎(PBC)和非酒精性脂肪性肝炎(NASH)。Intercept于2002年在纽约成立,在美国、欧洲和加拿大都有业务。欲了解更多信息,请访问www.interceptpharma.com或在Twitter和LinkedIn上与公司联系。 联系人 有关Intercept的更多信息,请联系: 投资者查询:investors@interceptpharma.com 媒体查询:Media@interceptpharma.com 资料来源:Intercept Pharmaceuticals公司。

以上中文文本为机器翻译,存在不同程度偏差和错误;偶尔因源网页结构局限,内容无法一次完整呈现。请理解并参考原站原文阅读。

阅读原文